01 2Gowling Lafleur Henderson LLP
02 4Gowling WLG (Canada) LLP
03 1Gowlings
01 21338895
02 21338937
03 12409930
04 12410201
05 12497353
01 7Zoledronic Acid
01 3Concentrate Solution
02 4Solution
01 22014-02-04
02 22014-02-25
03 12021-05-09
04 12021-06-18
05 12023-09-15
Patent Expiration Date : 2014-02-25
Date Granted : 1997-02-25
Brand Name : ZOMETA
Patent Number : 1338937
Filing Date : 1987-11-19
Strength per Unit : 4 mg / 5 mL
Dosage Form : Concentrate Solution
Human Or VET : Human
Route of Administration : I.V.
Patent Expiration Date : 2014-02-25
Date Granted : 1997-02-25
Patent Expiration Date : 2014-02-04
Date Granted : 1997-02-04
Brand Name : ZOMETA
Patent Number : 1338895
Filing Date : 1987-07-29
Strength per Unit : 4 mg / 5 mL
Dosage Form : Concentrate Solution
Human Or VET : Human
Route of Administration : I.V.
Patent Expiration Date : 2014-02-04
Date Granted : 1997-02-04
Patent Expiration Date : 2021-05-09
Date Granted : 2012-08-28
Brand Name : ZOMETA
Patent Number : 2409930
Filing Date : 2001-05-09
Strength per Unit : 4 mg / 5 mL
Dosage Form : Concentrate Solution
Human Or VET : Human
Route of Administration : I.V.
Patent Expiration Date : 2021-05-09
Date Granted : 2012-08-28
Patent Expiration Date : 2014-02-04
Date Granted : 1997-02-04
Brand Name : ACLASTA
Patent Number : 1338895
Filing Date : 1987-07-29
Strength per Unit : 5 mg / 100 mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2014-02-04
Date Granted : 1997-02-04
Patent Expiration Date : 2014-02-25
Date Granted : 1997-02-25
Brand Name : ACLASTA
Patent Number : 1338937
Filing Date : 1987-11-19
Strength per Unit : 5 mg / 100 mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2014-02-25
Date Granted : 1997-02-25
Patent Expiration Date : 2023-09-15
Date Granted : 2012-08-28
Brand Name : ACLASTA
Patent Number : 2497353
Filing Date : 2003-09-15
Strength per Unit : 5 mg / 100 mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2023-09-15
Date Granted : 2012-08-28
Patent Expiration Date : 2021-06-18
Date Granted : 2010-10-26
Brand Name : ACLASTA
Patent Number : 2410201
Filing Date : 2001-06-18
Strength per Unit : 5 mg / 100 mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2021-06-18
Date Granted : 2010-10-26
LOOKING FOR A SUPPLIER?
Market Place
